International User Meeting will return
Thar Instruments has revealed that its TharSFC International Users Meeting will return to North America early in 2009...
Thar Instruments has revealed that its TharSFC International Users Meeting will return to North America early in 2009.
After holding both regional and international meetings in Europe during 2008, the company will host the meeting at the Hilton Newark Penn Station in New Jersey, USA on 6 February 2009. The company considered customer travel budgets and time restrictions when deciding on the location and one-day duration of the meeting.
The vice president of Thar Instruments, Todd Palcic said, "We chose the Hilton Newark because of its rare combination of rail, ground and air transportation options and close proximity to many of the world’s pharmaceutical companies."
In addition to the meeting on 6 February, the company will host a cocktail reception on 5 February and will offer an excursion to Manhattan on the evening of 6 February. To register or to find out more about the company, visit the website at www.tharsfc.com
LC–MS/MS-Based System Used to Profile Ceramide Reactions to Diseases
April 26th 2024Scientists from the University of Córdoba in Córdoba, Spain recently used liquid chromatography–tandem mass spectrometry (LC–MS/MS) to comprehensively profile human ceramides to determine their reactions to diseases.
Inside the Laboratory –– Women in Separation Science Edition
April 25th 2024Inside the Laboratory is a joint series with LCGC and Spectroscopy, profiling analytical scientists and their research groups at universities all over the world. This series spotlights the current chromatographic and spectroscopic research their groups are conducting, and the importance of their research in analytical chemistry and specific industries. In this “Inside the Laboratory –– Women in Separation Science” special edition PDF, we profile four industry leaders and the impact that their research is having in specific fields such as environmental analysis, forensics, national security, and drug development.
